Author:
Vestri Helliner S,Maianu Lidia,Moellering Douglas R,Garvey W Timothy
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference38 articles.
1. Ader M, Garvey WT, Phillips LS, Nemeroff CB, Weinberger DR, Gharabawi G et al (2005). Glucoregulation and adiposity with antipsychotic therapy in schizophrenia. National meeting of the American Psychiatric Association, Abstract NR828 (published online at: http://www.psych.org/edu/other_res/lib_archives/archives/meetings/2005nra.cfm ).
2. Ananth J, Kolli S (2005). Atypical antipsychotic agents and increased risk of diabetes: class action or differential action? Expert Opin Drug Saf 4: 55–68.
3. Ananth J, Venkatesh R, Burgoyne K, Gunatilake S (2002). Atypical antipsychotic drug use and diabetes. Psychother Psychosom 71: 244–254.
4. Aravagiri M, Marder SR, Yuwiler A, Midha KK, Kula NS, Baldessarini RJ (1995). Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat. Neuropsychopharmacology 13: 235–247.
5. Aravagiri M, Yuwiler A, Marder SR (1998). Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat. Psychopharmacology 139: 356–363.
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献